PAMU
IGMS

Pictet Asset Management (UK)’s IGM Biosciences IGMS Stock Holding History

Pictet Asset Management (UK)’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$36.5M Buy
439,297
+70,034
+19% +$5.19M 0.04% 408
2021
Q1 		$28.3M Sell
369,263
-40,880
-10% -$3.72M 0.03% 430
2020
Q4 		$36.2M Buy
410,143
+128,061
+45% +$9M 0.05% 371
2020
Q3 		$20.8M Sell
282,082
-21,008
-7% -$1.24M 0.03% 424
2020
Q2 		$22.1M Buy
303,090
+242,876
+403% +$14.8M 0.04% 383
2020
Q1 		$3.38M Buy
+60,214
New +$2.64M 0.01% 741

Other funds holding IGMS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pictet Asset Management (UK)'s IGMS Position: Q2 2021 in Review

Pictet Asset Management (UK) increased its IGM Biosciences (IGMS) stake by 19% in Q2 2021, buying an estimated $5.19M and bringing the position to 439,297 shares worth $36.5M. The position accounts for 0.04% of the portfolio, ranked #408.

Pictet Asset Management (UK) first reported a position in IGMS in Q1 2020 and has held it in 6 quarters since. 104 funds tracked by Wall St. Rank hold IGMS as of Q2 2021.

  • Pictet Asset Management (UK) held 439,297 shares of IGM Biosciences worth $36.5M as of Q2 2021.
  • Pictet Asset Management (UK) bought 70,034 IGM Biosciences shares in Q2 2021, an estimated $5.19M.
  • IGM Biosciences made up 0.04% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #408 holding.
  • Pictet Asset Management (UK) first reported a position in IGM Biosciences in Q1 2020 and has held it in 6 quarters since.
  • 104 funds tracked by Wall St. Rank held IGM Biosciences as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.